Autism Spectrum Disorder Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• Children and teenagers between 5 and 18 years old (inclusive)
• Children who have been officially diagnosed with Autism Spectrum Disorder (ASD) using specific standard diagnostic tools
• Children whose autism-related behavioral problems are rated as "moderate" or higher by a medical professional using a standard rating scale
• Children who have a parent or legal guardian who can give consent on their behalf and is willing to fill out questionnaires about the child's behavior and development throughout the study
• Children who are eligible for medical cannabis treatment as approved by the Israeli Ministry of Health under a specific official procedure (confirm with trial site)

Who may not be able to join:

• Children who are already using cannabis, antipsychotic medications, or stimulant medications
• Children who have heart, liver, kidney, or blood-related medical conditions
• Children who have an active seizure disorder or epilepsy — though children who have been completely seizure-free for more than 3 years may still be eligible
• Children who have taken part in another clinical trial or received an experimental treatment in the 30 days before this trial starts
• Children who currently have a diagnosis of bipolar disorder, major depression, psychosis, schizophrenia, or PTSD
• Children whose non-excluded psychiatric medications have been changed within the 4 weeks before the trial begins
• Children who are allergic to cannabinoids or to any ingredient in the PEA tablet used in the study
• Children with a history of substance or alcohol misuse, or whose initial drug screening test shows signs of drug use
• Children who, in the doctor's judgment, would be at unacceptable risk by participating in the study

Important: Always verify eligibility with the trial site directly before applying.